Literature DB >> 30523365

[Comparison of sublingual and intravenous administration of lorazepam in psychiatric emergencies in emergency medical services].

D Schwerthöffer1, F-G Pajonk2.   

Abstract

BACKGROUND: Agitation is a frequent reason for emergency physician calls in psychiatric emergencies in the German preclinical emergency medical system. Benzodiazepines have proven to be effective in treating acute agitation. Although lorazepam has beneficial clinical and pharmacological properties it is hardly used by emergency physicians. The sublingual administration of lorazepam has many advantages compared to intravenous administration.
MATERIAL AND METHODS: In an interventional trial lasting 18 months the efficacy, tolerance and onset of effects of sublingual and intravenous lorazepam in patients with agitation states in emergency duties were compared. The randomization to the intervention groups was subject to a time criterion. The sublingual administration of lorazepam over a period of 9 months was followed by an intravenous administration over the same period of time. The psychometric scales used were: PANSS-EC, CGI, CGI-Change, agitation-calmness evaluation scale, visual analog scale and sedation scale. Response to the intervention was defined by a 40% reduction on the PANSS-EC scale.
RESULTS: A total of 37 individuals participated in the study (sublingual: n = 22, intravenous: n = 15). Lorazepam was effective in treating acute agitation. The effectiveness and tolerance of sublingual and intravenous lorazepam administration seems to be comparable.
CONCLUSION: Sublingual administration of lorazepam is effective for treating acute agitation in emergency medical services.

Entities:  

Keywords:  Agitation; Benzodiazepines; Lorazepam; Psychiatric emergency; Sublingual

Year:  2018        PMID: 30523365     DOI: 10.1007/s00101-018-0513-7

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  36 in total

1.  [Psychotropic substances in the area of preclinical intensive care medicine].

Authors:  F X Huber; L Herzog; P J Meeder; J Buchholz
Journal:  Gesundheitswesen       Date:  2001-01

Review 2.  [The pharmacology of benzodiazepines].

Authors:  Heinz Bönisch
Journal:  Pharm Unserer Zeit       Date:  2007

3.  [Psychiatric emergencies in preclinical emergency service; incidence, treatment and evaluation by emergency physicians and staff].

Authors:  F G Pajonk; H H Bartels; P Biberthaler; T Bregenzer; H Moecke
Journal:  Nervenarzt       Date:  2001-09       Impact factor: 1.214

4.  Problems and costs associated with alcohol and drug abuse in emergency medicine.

Authors:  F-X Huber; T Hackert; P J Meeder
Journal:  Eur J Health Econ       Date:  2006-09

5.  A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model.

Authors:  J Barr; K Zomorodi; E J Bertaccini; S L Shafer; E Geller
Journal:  Anesthesiology       Date:  2001-08       Impact factor: 7.892

Review 6.  Benzodiazepines in the intensive care unit.

Authors:  C C Young; R C Prielipp
Journal:  Crit Care Clin       Date:  2001-10       Impact factor: 3.598

Review 7.  Pharmacological management of agitation in emergency settings.

Authors:  A Yildiz; G S Sachs; A Turgay
Journal:  Emerg Med J       Date:  2003-07       Impact factor: 2.740

Review 8.  [Psychopharmacological treatment in the pre-clinical emergency medicine].

Authors:  F-G Pajonk; B Fleiter
Journal:  Anaesthesist       Date:  2003-07-10       Impact factor: 1.041

Review 9.  Midazolam and other benzodiazepines.

Authors:  K T Olkkola; J Ahonen
Journal:  Handb Exp Pharmacol       Date:  2008

10.  Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation.

Authors:  Robert W Baker; Bruce J Kinon; Gerald A Maguire; Hong Liu; Angela L Hill
Journal:  J Clin Psychopharmacol       Date:  2003-08       Impact factor: 3.153

View more
  1 in total

1.  [Retraction Note to: Comparison of sublingual and intravenous administration of lorazepam in psychiatric emergencies in emergency medical services].

Authors:  D Schwerthöffer; F-G Pajonk
Journal:  Anaesthesist       Date:  2019-08       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.